title: Reduction of lung distensibility in acromegaly after suppression of growth hormone hypersecretion.
abstract: Whether the growth of the lungs in acromegaly is due to alveolar hypertrophy or alveolar hyperplasia is a subject of debate. To discriminate these hypotheses, we compared pulmonary distensibility and diffusing capacity among 11 patients with active acromegaly and 11 matched control subjects, evaluating the response of pulmonary distensibility and diffusing capacity to suppression of growth hormone (GH) hypersecretion. We performed lineal and exponential analyses of quasistatic pressure-volume curves. Patients with active acromegaly had a greater TLC, lung compliance, and shape constant, K, than did normal subjects. We found no significant differences between the study groups in carbon monoxide diffusing capacity or diffusing capacity per unit of alveolar volume. After treatment, patients with inactive acromegaly showed a reduced TLC (6.95 +/- 1.40 [mean +/- SD] L versus 6.35 +/- 1.23 L), reduced lung compliance (3.61 +/- 0.90 L/kPa versus 2.36 +/- 0.79 L/ kPa), reduced K coefficient (2.62 +/- 0.65 kPa(-)(1) versus 1.35 +/- 0.40 kPa(-)(1)), and increased maximal recoil pressure (1.74 +/- 0.38 kPa versus 2.28 +/- 0.25 kPa). We conclude that the increased lung distensibility with normal diffusion capacity demonstrated in patients with active acromegaly, which was partly reversible after suppression of GH hypersecretion, suggests that lung growth in acromegaly may result from an increase in alveolar size.
authors.affiliation: Pulmonary Service and Endocrinology Service, Hospital Universitario La Paz, Madrid, Spain. fgr01m@jazzfree.com
authors.forename: F
authors.initials: F
authors.lastname: García-Río
authors.forename: J M
authors.initials: JM
authors.lastname: Pino
authors.forename: J J
authors.initials: JJ
authors.lastname: Díez
authors.forename: A
authors.initials: A
authors.lastname: Ruíz
authors.forename: C
authors.initials: C
authors.lastname: Villasante
authors.forename: J
authors.initials: J
authors.lastname: Villamor
mesh_terms: D000172:Acromegaly / Q000150:complications / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy*; D000328:Adult; D000368:Aged; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D008170:Lung Compliance; D008176:Lung Volume Measurements; D008297:Male; D008875:Middle Aged
chemical_list: D013006:Growth Hormone